- Brand names:
- Pharmaceutical Company:
- Condition/Indication: Primary biliary cholangitis
- Meeting Date: November 2020
- Public Summary Document (PSD) November 2020 PBAC Meeting - (PDF 1653KB)
- Public Summary Document (PSD) November 2020 PBAC Meeting - (Word 456KB)
Obeticholic acid – November 2020
Obeticholic acid: Tablet 5 mg, Tablet 10 mg; Ocaliva®
Last updated
19 March 2021